Catalyst Wire Dossier Catalyst Wire Dossier

breath-operated albuterol inhaler

albuterol · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for breath-operated albuterol inhaler, covering 2021-11-30 to 2021-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique [Phase 2]

See pricing